Literature DB >> 7603139

Control of group C meningococcal disease in Australian aboriginal children by mass rifampicin chemoprophylaxis and vaccination.

M C Pearce1, J W Sheridan, D M Jones, G W Lawrence, D M Murphy, B Masutti, C McCosker, V Douglas, D George, A O'Keefe.   

Abstract

An outbreak of 12 cases of meningitis, 11 caused by Neisseria meningitidis serogroup C, occurred at Doomadgee from September, 1990, to April, 1991. The incidence of meningitis was 17.55/10(3) person-years. Only children aged 1-10 years were affected. In October, 1990, or shortly thereafter, 473/509 children aged between 1 and 15 years inclusive had one dose of Mencevax AC. From the time of vaccination until April, 1991, a further eight cases occurred, six in vaccinated children. Vaccine efficacy in 1-15 year olds was calculated as 77%. Despite this, in April, 1991, the prevalence of antibody to group C polysaccharide in vaccinated children (78%) was not significantly different from that in unvaccinated children and adults. 46 nonresponders were revaccinated, and, in February, 1992, 78% had antibodies to group C polysaccharide. In April, 1991, an estimated 3.0% of the population had group C organisms, carriage being directly related to household crowding. In June, 1991, 2 months after mass prophylaxis with rifampicin, none of these individuals were carriers. In October, 1991, the carriage rate of group C organisms was 0.64%. There have been no further cases caused by the epidemic strain. Although uncrowded housing is a basic need, mass chemoprophylaxis and two doses of vaccine for children should be used in similar outbreaks.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7603139     DOI: 10.1016/s0140-6736(95)92651-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  3 in total

1.  Preventative strategies on meningococcal disease.

Authors:  R T Mayon-White; P T Heath
Journal:  Arch Dis Child       Date:  1997-03       Impact factor: 3.791

Review 2.  Meningococcal vaccines. Current status and future possibilities.

Authors:  H Peltola
Journal:  Drugs       Date:  1998-03       Impact factor: 9.546

3.  Outbreaks of meningococcal meningitis in non-African countries over the last 50 years: a systematic review.

Authors:  Femke van Kessel; Caroline van den Ende; Anouk M Oordt-Speets; Moe H Kyaw
Journal:  J Glob Health       Date:  2019-06       Impact factor: 4.413

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.